Latest News

Alzheimer's prevention trial to monitor reactions to higher disease risk status

A new clinical trial will soon begin testing whether early medical intervention in people at risk for Alzheimer's can slow down progression of disease pathology before symptoms emerge. As part of the overall prevention trial, neurodegenerative ethics experts will monitor how learning about their risk of developing Alzheimer's impacts trial participants.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • MS drug candidate shows new promise

  • Pathway that contributes to Alzheimer's disease revealed by research

  • Domestic violence likely more frequent for same-sex couples

  • Physical activity in older adults linked to brain white-matter integrity

  • Targeted radiation, drug therapy combo less toxic for recurrent head, neck cancers

  • 3-D shape processing in brain: New discovery on how objects, places are processed

  • Suicide Prevention Requires Access to Effective, Evidence-Based Treatment

  • Down Syndrome helps researchers understand Alzheimer's disease

  • Providing private mental health service to veterans: Hurdles, challenges, advice

  • Gun deaths twice as high among African-Americans as white citizens in US

  •